237 related articles for article (PubMed ID: 23255884)
21. Current status of clinical trials for small cell lung cancer.
Fischer B; Arcaro A
Rev Recent Clin Trials; 2008 Jan; 3(1):40-61. PubMed ID: 18474014
[TBL] [Abstract][Full Text] [Related]
22. New agents in the treatment of small-cell lung cancer: focus on gemcitabine.
Chiappori AA; Rocha-Lima CM
Clin Lung Cancer; 2003 Jan; 4 Suppl 2():S56-63. PubMed ID: 14720338
[TBL] [Abstract][Full Text] [Related]
23. New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric Oncology.
Balducci L; Falandry C; List A
Curr Oncol Rep; 2022 Dec; 24(12):1695-1703. PubMed ID: 35986858
[TBL] [Abstract][Full Text] [Related]
24. Targeting DNA damage repair in small cell lung cancer and the biomarker landscape.
Sen T; Gay CM; Byers LA
Transl Lung Cancer Res; 2018 Feb; 7(1):50-68. PubMed ID: 29535912
[TBL] [Abstract][Full Text] [Related]
25. Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer.
Melosky B; Cheema PK; Brade A; McLeod D; Liu G; Price PW; Jao K; Schellenberg DD; Juergens R; Leighl N; Chu Q
Oncologist; 2020 Nov; 25(11):981-992. PubMed ID: 32860288
[TBL] [Abstract][Full Text] [Related]
26. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Dwan K; Boland A; Bates V; Vecchio F; Dundar Y; Jain P; Green JA
Cochrane Database Syst Rev; 2016 May; (5):CD010383. PubMed ID: 27223332
[TBL] [Abstract][Full Text] [Related]
27. Economic burden of advanced lung cancer patients treated by gefitinib alone and combined with chemotherapy in two regions of China.
Yang K; Hua S; Wei W; Yang C; Zhu X; Li SC
J Med Econ; 2023; 26(1):1424-1431. PubMed ID: 37855437
[TBL] [Abstract][Full Text] [Related]
28. Current treatments for advanced stage non-small cell lung cancer.
Stinchcombe TE; Socinski MA
Proc Am Thorac Soc; 2009 Apr; 6(2):233-41. PubMed ID: 19349493
[TBL] [Abstract][Full Text] [Related]
29. Use of Immunotherapy in Extensive-Stage Small Cell Lung Cancer.
Konala VM; Madhira BR; Ashraf S; Graziano S
Oncology; 2020; 98(11):749-754. PubMed ID: 32663833
[TBL] [Abstract][Full Text] [Related]
30. Prospects of targeted and immune therapies in SCLC.
Hendriks LEL; Menis J; Reck M
Expert Rev Anticancer Ther; 2019 Feb; 19(2):151-167. PubMed ID: 30590971
[No Abstract] [Full Text] [Related]
31. Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer.
Yu L; Lai Q; Gou L; Feng J; Yang J
J Drug Target; 2021 Jan; 29(1):1-11. PubMed ID: 32700566
[TBL] [Abstract][Full Text] [Related]
32. Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers.
Epstein RS; Weerasinghe RK; Parrish AS; Krenitsky J; Sanborn RE; Salimi T
J Med Econ; 2022; 25(1):108-118. PubMed ID: 34927520
[TBL] [Abstract][Full Text] [Related]
33. Small cell lung cancer: where do we go from here?
Byers LA; Rudin CM
Cancer; 2015 Mar; 121(5):664-72. PubMed ID: 25336398
[TBL] [Abstract][Full Text] [Related]
34. Survival outcomes and prognostic nutritional index in very elderly small-cell lung cancer patients: importance of active treatment and nutritional support.
Almuradova E; Menekse S
Aging Male; 2023 Dec; 26(1):2251573. PubMed ID: 37642430
[TBL] [Abstract][Full Text] [Related]
35. Role of epidermal growth factor receptor in lung cancer and targeted therapies.
Liu TC; Jin X; Wang Y; Wang K
Am J Cancer Res; 2017; 7(2):187-202. PubMed ID: 28337370
[TBL] [Abstract][Full Text] [Related]
36. 1p/19q codeletion and RET rearrangements in small-cell lung cancer.
Lu H; Xu H; Xie F; Qin J; Han N; Fan Y; Mao W
Onco Targets Ther; 2016; 9():3571-7. PubMed ID: 27366094
[TBL] [Abstract][Full Text] [Related]
37. Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung.
Wang WZ; Shilo K; Amann JM; Shulman A; Hojjat-Farsangi M; Mellstedt H; Schultz J; Croce CM; Carbone DP
Cell Death Dis; 2021 Jun; 12(6):577. PubMed ID: 34088900
[TBL] [Abstract][Full Text] [Related]
38. Irinotecan: future directions in small-cell lung cancer.
Sandler A
Clin Lung Cancer; 2001 May; 2 Suppl 2():S9-S13. PubMed ID: 14725724
[TBL] [Abstract][Full Text] [Related]
39. Surgery for limited-stage small-cell lung cancer.
Barnes H; See K; Barnett S; Manser R
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011917. PubMed ID: 28429473
[TBL] [Abstract][Full Text] [Related]
40. Advances in antiangiogenic treatment of small-cell lung cancer.
Lu H; Jiang Z
Onco Targets Ther; 2017; 10():353-359. PubMed ID: 28138259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
